|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 215-218.
Prepublished online as a Blood First Edition Paper on June 10, 2004; DOI 10.1182/blood-2003-07-2367.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Brief report
Platelet-associated CD154 in immune thrombocytopenic purpura
Anne Solanilla,
Jean-Max Pasquet,
Jean-François Viallard,
Cécile Contin,
Christophe Grosset,
Julie Déchanet-Merville,
Maryse Dupouy,
Marc Landry,
Francis Belloc,
Paquita Nurden,
Patrick Blanco,
Jean-François Moreau,
Jean-Luc Pellegrin,
Alan T. Nurden, and
Jean Ripoche
From CNRS FRE 2617 and UMR 5540, Université de Bordeaux 2; CNRS EPI 9914, Institut Magendie Bordeaux; IFR no. 4 and Laboratoire d'Hématologie, Hôpital Cardiologique, Pessac; and Service de Médecine Interne, Hôpital du Haut-Lévêque, Pessac, France.
CD40-ligand (CD154) is expressed on activated CD4+ T lymphocytes and is essential for the T cell–dependent activation of B lymphocytes. CD154 is also expressed at the activated platelet surface. In this study, we show that platelet-associated CD154 is increased in immune thrombocytopenic purpura (ITP), a disease characterized by an autoimmune response against proteins of the platelet membrane. CD154 and its messenger RNA were also present in increased amounts in the megakaryocytes of patients with ITP. We found that platelet-associated CD154 is competent to induce the CD40-dependent proliferation of B lymphocytes, and we observed an in vitro CD154-dependent production of antibodies to the GPIIb/IIIa complex (integrin  IIb 3) when platelets and peripheral blood B lymphocytes from ITP patients with circulating anti-GPIIb/IIIa antibody were cultured together. Therefore, platelet-associated CD154 expression is increased in ITP and is able to drive the activation of autoreactive B lymphocytes in this disease.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. L. Sprague, B. D. Elzey, S. A. Crist, T. J. Waldschmidt, R. J. Jensen, and T. L. Ratliff
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles
Blood,
May 15, 2008;
111(10):
5028 - 5036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Elzey, N. W. Schmidt, S. A. Crist, T. P. Kresowik, J. T. Harty, B. Nieswandt, and T. L. Ratliff
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge
Blood,
April 1, 2008;
111(7):
3684 - 3691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Schallmoser, C Rosin, R Vormittag, M Brunner, D Dunkler, I Pabinger, and S Panzer
Specificities of Platelet Autoantibodies and Platelet Activation in Lupus Anticoagulant Patients: A Relation to their History of Thromboembolic Disease
Lupus,
August 1, 2006;
15(8):
507 - 514.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. D. Elzey, J. F. Grant, H. W. Sinn, B. Nieswandt, T. J. Waldschmidt, and T. L. Ratliff
Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation
J. Leukoc. Biol.,
July 1, 2005;
78(1):
80 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
